Abstract The inaugural robot-assisted urological procedure in a child was performed in 2002. This study aims to catalogue the impact of this technology by utilizing bibliographic data as a surrogate measure for global diffusion activity and to appraise the quality of evidence in this field. A systematic literature search was performed to retrieve all reported cases of paediatric robot-assisted urological surgery published between 2003 and 2016. The status of scientific community acceptance was determined using a newly developed analysis model named progressive scholarly acceptance. A total of 151 publications were identified that reported 3688 procedures in 3372 patients. The most reported procedures were pyeloplasty (n = 1923) and ureteral reimplantation (n = 1120). There were 16 countries and 48 institutions represented in the literature. On average, the total case volume reported in the literature more than doubled each year (mean value increase 236.6% per annum). The level of evidence for original studies remains limited to case reports, case series and retrospective comparative studies. Progressive Scholarly Acceptance charts indicate that robot-assisted techniques for pyeloplasty or ureteral reimplantation are yet to be accepted by the scientific community. Global adoption trends for robotic surgery in paediatric urology have been progressive but remain low volume. Pyeloplasty and ureteral reimplantation are dominant applications. Robot-assisted techniques for these procedures are not supported by high quality evidence at present. Next-generation robots are forecast to be smaller, cheaper, more advanced and customized for paediatric patients. Ongoing critical evaluation must occur simultaneously with expected technology evolution.
Introduction
It is a duty of clinical governance to monitor adoption processes for new technology items in healthcare [1] . On a global scale, inter-country differences in regulation approval policy, health system models and economics influence the already complicated and intriguing factors that drive the diffusion of healthcare innovation [2] . In parallel with evidence-based scrutiny of safety, quality and cost-effectiveness; it is important to also maintain ongoing assessment of technology adoption patterns to understand the scale and pace of change on a field of clinical practice.
Robot-assisted surgery has been one of the major technology items introduced to paediatric urology in the twenty-first century. Robot assistance has not yet enabled novel procedures, but instead has offered an alternative mode to undertake existing minimally invasive surgical approaches. Technological enhancements provided by robot assistance are promoted as offering improved operative performance capabilities and enabling minimally invasive approaches when they might otherwise not be considered [1, [3] [4] [5] .
Anecdotally, adoption of robot-assisted surgery has continued to promulgate in paediatric urology since it was first introduced in March 2002 when Peters et al. performed a robot-assisted laparoscopic pyeloplasty [1, 6, 7] . Several recent studies have interrogated major nationwide administrative databases in North America to empirically confirm increasing popularity of robot-assisted surgery in paediatric urology within this geographical region [8] [9] [10] . In the absence of global registries for robot-assisted paediatric urological surgery, this study utilizes bibliographic data as a surrogate measure for global technology diffusion activity and quality of evidence. The status of scientific community acceptance for robotic surgery in paediatric urology was determined using a newly developed and validated analysis model named Progressive Scholarly Acceptance [11, 12] .
Materials and methods

Search strategy
A systematic literature search of multiple electronic databases and grey literature sources was performed to retrieve all reported cases of paediatric robot-assisted urological surgery. The search strategy previously described by Cundy et al. was replicated, with extensions to include literature from 2003 to 2016 inclusively, and limitation to urological procedures only [1] . Two reviewers (SJDH, TPC) screened identified articles independently for relevance, with disagreements resolved by consensus. Due to inability to account for duplication of separately published data, studies reporting aggregated data from nationwide administrative databases such as the Paediatric Health Information System, Kids' Inpatient Database, and Perspective Database were excluded. Multi-institutional studies represented by C5 institutions were excluded for the same reason. Numerous data items were extracted from all included studies for tabulation. These data included patient numbers, procedure types, study design, geographical detail of institutional affiliations, and patient demographic details.
Progressive scholarly acceptance
The Progressive Scholarly Acceptance model is based on the theory by Riskin et al. that characterises evolution of an innovation (or any other new diagnostic or treatment item) into an ''expanding period'' and ''refining period'' [13] . The former typically represents an earlier experimental phase, and the latter represents a more matured period of establishment through iterative clinical and scientific endeavour. Some innovations promptly transition between periods, while others ''fail'' and never reach a period transition point. Methodology for the Progressive Scholarly Acceptance metric is centred on bibliometric analysis and is described by detail by Schnurman and Kondziolka [11, 12] . Progressive Scholarly Acceptance models were separately performed post hoc for pyeloplasty and ureteral reimplantation, as these procedures were identified as the dominant applications for robot-assisted surgery in paediatric urology. All relevant studies identified in the above search strategy were coded either as an ''initial investigation'' or ''refining study'' using the criteria outlined by Schnurman and Kondziolka [11, 12] . Both annual and compounding models were calculated. The compounding model is more conservative and used to determine the Progressive Scholarly Acceptance end-point, whereby the number of ''refining study'' articles surpasses the ''initial investigation'' articles [11, 12] . This transition point indicates an interval from which the majority of literature represents refinement in clinical practice, implying that the scientific community has accepted the initial questions of safety and efficacy [11, 12] .
Results
A total of 151 publications were identified that reported 3688 procedures in 3372 patients. The most reported robotic-assisted urological procedures in children were identified as pyeloplasty (n = 1923) and ureteral reimplantation (n = 1120). These two procedures predominate the literature and together represent 83% of the reported case volume. Further breakdown of variety of reported procedures and respective case volumes is summarised in Table 1 . There were 16 countries and 48 institutions represented in the literature, with the majority of publications contributed by North American institutions (Fig. 1) . The youngest patient identified was 1 month of age [14] and smallest patients weighed 4 kg [14, 15] .
There was a progressive trend of increasing volume of reported procedures per annum over the examined period (Fig. 2a ). This trend pattern was similar for the number of relevant publications per annum (Fig. 2b) . On average, the total case volume reported in the literature more than doubled each year (mean value increase 236.6% per annum). The cumulative number of reported procedures was increased by a mean value of 223.9% per annum. The level of evidence for original studies is limited to case reports, case series and retrospective comparative studies. No data was collected entirely prospectively and no randomized controlled trials were identified (Fig. 2c) . The temporal distribution pattern of literature quality of evidence was multimodal, with an early peak of case reports followed by later peaks of case series and comparative studies (Fig. 2c) . Progressive Scholarly Acceptance charts indicated that the scientific community has not accepted robot-assisted techniques for pyeloplasty or ureteral reimplantation (Fig. 3a, b ). An early convergence pattern was identified on the compounding chart for pyeloplasty, indicating a trend towards acceptance. Lack of convergence on the ureteral reimplantation chart implies that acceptance is unlikely to occur in the foreseeable future.
Discussion
Based on bibliographic data, global adoption trends since the introduction of robotic surgery in paediatric urology are progressive, but unimpressive compared to other specialty fields such as adult urology. The pattern of case volume reported over time corresponds with the early phases of the S-shaped diffusion of innovation curve described by Rogers [5, 16] . The highly varied case-mix in the literature is almost entirely comprised of reconstructive procedures. This is expected and reflective of the characteristic nature of surgery encountered in paediatric urology. Amongst the case-mix identified, pyeloplasty and ureteral reimplantation are dominant and together account for an overwhelming majority proportion of reported procedures. Progressive Scholarly Acceptance analysis indicates that these indications have not been accepted by the scientific community and remain in an ''expanding period'' of early adoption. While pyeloplasty and ureteral reimplantation applications do seem to continue to thrive, others have proven to be either rare or experimental, and therefore remain isolated amongst numerous singular procedures reported in the literature. Specific roles and case selection for robot-assisted techniques are yet to be clearly defined. This is reflected in the evolving characteristic of the literature that in recent years has included series of increasingly complex operations such as revision surgery [17] , simultaneous bilateral procedures [18] and procedures on younger patients [19] [20] [21] [22] . Robot-assisted surgery is promoted as an enabling technology that permits the reduced morbidities of minimally invasive techniques with clinical outcome benefits of ''gold-standard'' open techniques. Conventional laparoscopic pyeloplasty and ureteral reimplantation have achieved limited adoption worldwide despite these techniques existing for almost 20 years. Reasons for limited uptake are attributed to the inhibitive degree of technical difficulty associated with complex reconstructive surgery that includes abundant intracorporeal suturing [4, 23, 24] . The enhanced dexterity, precision, ergonomics and optics facilitated by robot-assistance are perceived to democratize minimally invasive surgery by making it more widely achievable. Studies of subscription-based administrative databases in North America confirm increasing rates of minimally invasive pyeloplasty and ureteral reimplantation, with robot-assisted approaches being performed up to four times more often than the conventional laparoscopic approaches in recent years [9, 10, 25] .
Evidence
In a broader perspective, the uptake of robotic technology in paediatric urology is circumspect when considered in the context of more than 3 million laparoscopic procedures having been performed worldwide using the da Vinci Surgical System (Intuitive Surgical, CA) platform. In adult urology, a number of procedures such as robot-assisted laparoscopic prostatectomy are now considered standard of care in some countries [26] . This degree of technology impact is not foreseeable in paediatric urology, especially when the literature informs us that only 41 institutions worldwide are performing robot-assisted urological surgery in children. Interestingly, the pervasiveness of technology diffusion for robot-assisted laparoscopic prostatectomy occurred without the support of high level of evidence data. It was only in 2016 that the first and only randomized controlled trial was published for this indication. This trial identified statistically non-significant differences in primary outcomes at 12 weeks post-operatively [27] . Evidence examining the use of paediatric robot-assisted urological surgery is of limited quality and restricted to Level III-IV based on the Oxford Centre for EvidenceBased Medicine (OCEBM) classification system. Most of the published literature is case reports (27/129; 20.9%) and case series (75/129; 58.1%); however, there has been improvement in the quality of evidence demonstrated by the publication of 21 original comparative studies between 2011 and 2016 compared to just 6 between 2003 and 2010. Emerging higher quality evidence indicates that outcomes for robot-assisted pyeloplasty [3, 9, 10] and ureteral reimplantation [28, 29] are largely comparable to open techniques. With this evidence failing to support meaningful outcome benefits for these dominant indications, a period of critical assessment must occur as a priority to more definitively inform the debate regarding the clinical role and cost-effectiveness of this technology [30] . Higher quality evidence must be aspired towards, and is achievable as demonstrated by the above-mentioned randomized controlled trial that threatens to cause interruption to the previously uninterrupted diffusion of robot-assisted prostate surgery [27, 31] .
Cost-effectiveness
Healthcare spending is under intense pressure of budget restraints and prioritized distribution of resources. Medical care has arguably never been more expensive. Any new technology in a modern healthcare system faces mounting pressure to prove cost-effectiveness. There were only several publications identified in this systematic review that investigated cost-effectiveness [32] . Interestingly, a recent cost-analysis study by Tedesco et al. identified that an annual case volume of 349 procedures was required to meet break-even costing and financially justify establishment of a paediatric robotic surgery program in their healthcare setting [33] . It is unlikely that this caseload would be achievable in a single tertiary paediatric centre. High expenses of existing robotic systems are a major barrier to accessibility and are widely regarded as the most limiting factor of this technology [2] . Given the almost 15 years period since robot-assisted surgery was introduced to paediatric urology, it is surprising that this literature field is represented by less than 50 institutions. Financial affordability must be prioritized to broaden clinical accessibility. In the coming years we can expect to see robot-assisted laparoscopic surgery become less synonymous with the da Vinci Surgical System Ò (Intuitive Surgical, CA, USA) [34] . Expiry of patents and growing presence of legitimate market competitors will diversify robotic technology in minimally invasive surgery. Future robotic technologies are forecast to not only be more affordable, but also smaller and better suited for use in children [5] .
Technology barriers
Operative domain is a major challenge. Many authors describe age ([4 years) and bladder size ([200 ml) criteria for intravesical (Cohen technique) robot-assisted laparoscopic ureteral reimplantation eligibility [4, 24, 35] . Workspace restrictions for 5 and 8 mm da Vinci Ò instruments in laparoscopic surgery have also been empirically tested in a laboratory setting [36] . In this pre-clinical randomized crossover study, 3-mm non-robotic laparoscopic instruments outperformed 5-and 8-mm robotic instruments for advanced bimanual operative tasks in constrained workspace volumes \200 cm 3 [36] . Currently, available robotic instruments are fundamentally designed for the adult patient, and confine many robot-assisted urological procedures to older children with larger operative workspace volumes. There is a need for next-generation robotic technology to be further optimized for performance in small workspaces.
Limitations
There are limitations of this study that are implicit with publication bias associated with bibliographic data. First, we rely on this data being fairly representative as a surrogate of actual surgical activity on a global scale. While the proportion of reported and unreported robot-assisted surgical activity is unknown, we consider it appropriate to expect that the rate of reporting is consistent and thus interpretation of trends are reliable. Bibliographic analysis, including the Progressive Scholarly Acceptance model, has previously been validated as a reliable measure to quantify innovation in surgical practice [11, 12, 37] . Second, there is an inevitable delay between surgical activity and literature reporting that must be appreciated when interpreting temporal trends.
Conclusion
Global adoption trends for robotic surgery in paediatric urology have been progressive but remain low volume in the context of overall surgical activity in this specialty, and compared to other specialties such as adult urology. Pyeloplasty and ureteral reimplantation are the overwhelmingly dominant applications for this technology at present. Robot-assisted techniques for these procedures are yet to be supported by high quality evidence from comparative studies or trials. The overall quality of evidence in the literature for this field is poor and predominantly represented by case reports and case series. It must be acknowledged that current surgical robots are first-generation technology. Next-generation technology is already under development and is forecast to be smaller in footprint, cheaper, more advanced and customized for paediatric patients. It will be important to ensure that ongoing critical clinical evaluation occurs simultaneously with technology evolution.
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